The microtubule (MT) associated protein Tau is instrumental for the regulation of MT 23 assembly and dynamic instability, orchestrating MT-dependent cellular processes. 24 Aberration in Tau post-translational modifications ratio deviation of spliced Tau isoforms 25 3 or 4 MT binding repeats (3R/4R) have been implicated in neurodegenerative tauopathies.
Introduction
activity requires Tau expression (16) . We have further revealed that NAP-Tau association 67 is mediated by direct interaction of NAP and Tau with MT end-binding proteins (EBs) (15, 68 17). 69 Clinical trials identified the potential efficacy of NAP (davunetide, CP201) in enhancing 70 short term memory in amnestic mild cognitive impairment patients (18). However, it was 71 not found to be an effective (though, well tolerated) treatment for progressive supranuclear 72 palsy (PSP) patients (19) . Because abnormal aggregation of Tau4R is a hallmark of PSP 73 pathophysiology (20), the current study aimed to determine whether NAP had a different 74 activity on either Tau3R or 4R. Our results now showed that NAP preferentially interacted 75 with Tau3R protein from rat brains and induced increased recruitment of human Tau3R to 76 MTs under zinc toxic condition in comparison to Tau4R. Furthermore, we showed that 77 NAP interaction with tubulin was inhibited by paclitaxel obstruction of Tau-binding sites 78 on MTs, confirming the requirement of Tau-MT interaction for NAP activity.
79

Results
80
Tau from 60-day-old rat brain does not associate with NAP under conditions that 81 Tau from newborn rat brain does 82 Different tubulin and Tau isotypes are expressed in the course of a rat brain development 83 (10, 21) . Newborn-rats predominantly express the Tau3R isoform while adults 84 predominantly express the Tau4R isoform (22) . Here, newborn and 60-day-old rat cerebral 85 cortex extracts were analyzed by immunoblotting, and prevailing expression of Tau3R or 86 4R was observed in the newborn or 60-day-old cortex protein lysate, respectively, as 87 expected ( Fig 1A) . Then, newborn and 60-day-old rat cortex protein lysates were exposed 88 to NAP affinity chromatography, and eluted proteins were analyzed by immunoblotting 89 with Tau3R and 4R, total-Tau (identifying all Tau isoforms), tubulin Tub2.1 (identifying 90 neuronal-enriched tubulin (23)) and TubβIII (identifying neuronal-specific tubulin (24)) 91 antibodies. Immunoreactivity for all tested antibodies was detected in the acid eluted 92 fraction from newborn rat brain extract ( Fig 1B) . However, no significant Tau or tubulin-93 like bands were observed in the eluted fractions from the mature rat extract under the 94 current experimental conditions ( Fig 1B) . affinity chromatography with the same protein extracts of rat brain cortex. Tau3R, total-101 Tau, and tubulin were identified in the NAP-binding fraction of the newborn rat cortical 102 brain extract, but essentially neither Tau nor tubulin was identified in the elution fraction 103 of the 60-day-old cortical brain extract (three independent experiments).
104
NAP induces increased recruitment of human Tau3R to MTs under zinc toxic 105 condition in comparison to Tau4R 106 In order to test the effect of NAP on the interactions of different Tau isoforms with MTs, 107 fluorescent recovery after photobleaching (FRAP) assay was performed (Fig 2) . mCherry-108 tagged human Tau3R and 4R proteins (S1 Fig.) were over-expressed in differentiated Here, we observed that treatment with extracellular zinc increased fluorescence recovery 117 87sec after photobleaching of both mCherry-Tau3R and 4R molecules (Fig 2A) . Analysis 118 with one-phase exponential association showed a significant decrease of Tau3R and 4R 119 immobile fractions ( Fig 2B and C) . NAP added together with zinc decreased fluorescence 120 recovery (Fig 2A) and thus significantly enhanced the immobile fraction of Tau3R and 4R 121 compared to treatment with zinc alone (Fig 2B and C) . However, while the Tau4R 122 immobile fraction was restored to untreated control level, while the immobile fraction of 123 Tau3R was further increased in comparison to control values and the difference between 124 Tau3R and 4R immobile fractions was found statistically significant ( Fig 2C) . Thus, NAP 125 treatment produces a more potent impact on 3R-, rather than on 4R-Tau association with Fig 3A and B) . Immunoreactivity of Tau3R appeared in both fractionswith and 146 without paclitaxel exposure ( Fig 3C) . As tubulin was washed away in the presence of 147 paclitaxel, whereas Tau3R remained bound to the NAP column, we suggest that NAP 148 interaction with tubulin required mediation of Tau ( Fig 3D) . To ascertain the specificity of 149 NAP binding, an affinity control column with eight-amino-acids inactive peptide Then, we assessed the protective activity of NAP against increased concentrations of 158 paclitaxel. For this purpose, differentiated N1E-115 cells were exposed to paclitaxel (5, 6 159 and 7 µM) with or without NAP (10 -15 , 10 -12 , 10 -9 M) for 4hrs. Cell viability, measured by 160 mitochondrial activity, was significantly reduced following the 4hr-incubation period with 161 paclitaxel. However, co-treatment with NAP (10 -12 and 10 -9 M, but not 10 -15 M) protected 162 against the lowest tested concentration of paclitaxel -5µM (Fig 4) , but not against increased 163 concentrations of paclitaxel -6 and 7µM. These results suggest a requirement of direct 164 Tau-MT interaction for NAP activity, confirming our previously published data that 165 showed requirement of Tau expression for NAP protective capabilities (16). The only difference between the two Tau isoforms (3R and 4R) is the presence of the exon 210 10 coding sequence comprising an extra MT-binding repeat in Tau4R (Fig 5A, red   211 sequence) which is excluded during alternative splicing in Tau3R (40). Elm prediction 212 analysis (41) of the whole Tau sequence identified cyclin A-docking motif within the 213 translated sequence of exon 10 ( Fig 5A, S1 Table) . Whereas cyclin-dependent kinase (Cdk) and ensuing decrease of EB protein association ( Fig 5B) . In this respect, we have 225 previously reported that NAP reduces Tau phosphorylation at Ser262 (30), Ser202/Thr205, 226 and Thr231 (46) residues, but does not exhibit a significant impact on Tau phosphorylation 227 level at Thr181 (19) . Intriguingly, Thr181 is on one of the predicted Tau 228 binding/phosphorylation motifs of Cks1 modulating the activity of Cdk (Fig 5A, S1 Table) .
229
As opposed to rodents, Tau3R is abundant alongside with Tau4R in the human adult brain. translated protein sequence of exon 10, which is spliced in Tau3R, is marked by red.
252
Functional motifs, predicted by Elm analysis (41) (S1 Table) were incubated with brain extract, washed as described above, and eluted with glycine 0.1 292 M pH 2.6.
293 3] The control column contained an inactive peptide CKKKGGVLGGGSALL (the linker 294 peptide is in bold) described in supplemental materials and methods (S1 File and S2 Fig) .
295
SDS-PAGE and western blot analysis 296
The flow-through, wash fractions and elution fractions were separated by 10% or 12% 297 SDS polyacrylamide gel electrophoresis (SDS-PAGE) followed by protein staining using (26)) that were incubated with brain 539 extracts and DMSO in the absence and presence of paclitaxel. Western blotting analysis 540 with anti Tau RD3 detected Tau3R presence in the loaded material, column flow-through 541 and column wash, but did not detect Tau3R in the acid elution fractions of both the 542 columns. In contrast, tubulin antibodies -Tub2.5 identified tubulin-like bands also in the 543 elution fractions with no apparent influence of paclitaxel treatment. 544 S1 Table. Elm prediction analysis of Tau (NP_005901) exon 10 translation sequence. 545 Elm analysis (41) predicted functional motifs of the translation sequence of spliced exon 546 10 (VQIINKKLDLSNVQSKCGSKDNIKHVPGGGS) of Tau isoform 2 (NP_005901).
547
DOC_CYCLIN_RxL_1 motif appeared only once in full Tau sequence. 
